|
|
 |
|
Viewing report
|
|
|
|
Indonesia Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 97
Business Monitor International's Indonesia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Indonesia's pharmaceuticals and healthcare industry.
In the BMI Business Environment Rating matrix for Q110, Indonesia moves down one place to occupy 13th out of the 15 regional markets surveyed in the Asia Pacific region. The main drawbacks to investment include corruption, low per-capita spending on pharmaceuticals and a small proportion of the elderly in the country. However, factors such as annual growth of its pharmaceutical market, together with rising population numbers and a relatively solid political and economic base, should continue to attract multinationals to the country. The publisher therefore envisage that sales of pharmaceutical products will increase over the next 10 years, with sales of prescription drugs and over-the-counter (OTC) medications expected to grow from US$2.79bn in 2008 to US$7.80bn in 2019, thus representing compound annual growth rates (CAGRs) in local currency terms of 7.99% and 9.14% for 2009-14 and 2014-19, respectively.
As part of efforts to expand domestic pharmaceutical manufacturers’ market potential, Indonesia’s Pharmaceutical Association, GP Farmasi, announced that the domestic pharmaceutical sector hoped to establish foreign-owned factories locally by co-operating with drug manufacturers from within the Association of Southeast Asian Nations (ASEAN) members. The aim is to establish an industrial base for raw materials in Indonesia. Data produced by GP Farmasi shows that the market value for pharmaceutical products in the ASEAN region could rise to US$8bn by the end of 2009, compared with US$7bn in 2008. Meanwhile, the National AIDS Commission announced that in order to guarantee a continuous supply of antiretroviral (ARV) drugs for patients with HIV/AIDS, Indonesia will in future receive donations in the form of drugs instead of cash payments. The new arrangement has been secured with the Global Fund for AIDS, Tuberculosis and Malaria. For 2009, the Ministry of Health has earmarked IDR39bn (US$41.24mn) to help fight the spread of the disease and to provide free ARV treatment. For its part, the global fund has committed IDR22bn (US$23.26mn) for the same program.
Elsewhere, Singapore-based drug development company Innogene Kalbiotech Private Ltd announced that it had signed a Memorandum of Understanding with a Malaysian clinical research organisation, Info Kinetics Sdn Bhd to provide accredited Bioavailability and Bioequivalence studies in Indonesia. Both companies have entered into a joint venture agreement to establish PT Pharma Kinetics, which will be based in a hospital in Jakarta, Indonesia. The company’s operations will be supported by PT Pharma Metric Labs, an Indonesian-based BA/BE research organisation set up by Innogene in 2005. In other developments, US-based Bristol-Myers Squibb announced that it had sold certain Asian assets to Japan’s Taisho Pharmaceuticals, which bought select OTC and consumer health products in Indonesia, Thailand and the Philippines, as well as certain other Asia Pacific countries. The medicines included Tempra (paracetamol), Counterpain (piroxicam + methyl salicylate + menthol + eugenol), Theragran (multivitamins), Engran (multivitamins), Ceetrus (ascorbic acid) and the Keri moisturiser range.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Indonesia Pharmaceuticals and Healthcare Report Q4 2010
Indonesia Pharmaceuticals and Healthcare Report Q1 2012
Indonesia Pharmaceuticals and Healthcare Report Q3 2011
Indonesia Pharmaceuticals and Healthcare Report Q4 2011
Indonesia Pharmaceuticals & Healthcare Report Q3 2007
Biopharmaceuticals in South East Asia
Singapore Pharmaceuticals and Healthcare Report Q1 2012
Weight Management in Indonesia
Serbia Pharmaceuticals and Healthcare Report Q1 2011
Plasters and Bandages Market in Indonesia to 2014 (OTC Healthcare)
|
|
|
|
